The bank sees room for another small guidance upgrade, but thinks investors will care more about where Novo goes next than about the quarter itself.
Recap by typeshit. Post by Investseekers on X.
Beauty companies are reportedly exploring products aimed at facial volume loss in people who have lost weight on GLP-1 drugs.
A short Fox16 social clip points to GLP-1 users shifting how they drink when they go out, with the full story linked in the station's bio.
A Facebook share points to shifting drinking habits in pubs and bars as more people take GLP-1 medications, with the full story linked.
Food Dive reports the Atkins brand is shifting its pitch toward lapsed GLP-1 users, a growing group food companies are now chasing.
Korean hospitals start prescribing Hanmi's GLP-1 drug, the first developed in the country, turning the local obesity market into a three-way race.
Roy writes for people on Ozempic or Wegovy worried about later effects, pointing to big trials that tallied side effects.
Loading…